BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 35689747)

  • 1. Immature PIT1-Lineage Pituitary Neuroendocrine Tumor: a 17-Year-Old Male with Pathogenic AIP Mutation.
    Lu R; Pu C; Pekmeczi M; Perry A
    Endocr Pathol; 2022 Sep; 33(3):414-416. PubMed ID: 35689747
    [No Abstract]   [Full Text] [Related]  

  • 2. [Plurihormonal PIT1-lineage pituitary neuroendocrine tumors: a clinicopathological study].
    Duan ZJ; Feng J; Zhao HQ; Wang HD; Gui QP; Zhang XF; Ma Z; Hu ZJ; Xiang L; Qi XL
    Zhonghua Bing Li Xue Za Zhi; 2023 Oct; 52(10):1017-1024. PubMed ID: 37805393
    [No Abstract]   [Full Text] [Related]  

  • 3. [Overview of the New World Health Organization Classification of Pituitary Neuroendocrine Tumors].
    Kurosaki M
    No Shinkei Geka; 2023 Sep; 51(5):910-916. PubMed ID: 37743343
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [New pathological classification and clinical implications of pituitary neuroendocrine tumors of the 2022 WHO version].
    Xie J; Wu ZB
    Zhonghua Yi Xue Za Zhi; 2022 Dec; 102(47):3723-3726. PubMed ID: 36517420
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overview of the 2022 WHO Classification of Pituitary Tumors.
    Asa SL; Mete O; Perry A; Osamura RY
    Endocr Pathol; 2022 Mar; 33(1):6-26. PubMed ID: 35291028
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pangenomic Classification of Pituitary Neuroendocrine Tumors.
    Neou M; Villa C; Armignacco R; Jouinot A; Raffin-Sanson ML; Septier A; Letourneur F; Diry S; Diedisheim M; Izac B; Gaspar C; Perlemoine K; Verjus V; Bernier M; Boulin A; Emile JF; Bertagna X; Jaffrezic F; Laloe D; Baussart B; Bertherat J; Gaillard S; Assié G
    Cancer Cell; 2020 Jan; 37(1):123-134.e5. PubMed ID: 31883967
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Update on the Genetics of Pituitary Tumors.
    Barry S; Korbonits M
    Endocrinol Metab Clin North Am; 2020 Sep; 49(3):433-452. PubMed ID: 32741481
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pituitary neuroendocrine tumors (PitNETs): nomenclature evolution, not clinical revolution.
    Asa SL; Asioli S; Bozkurt S; Casar-Borota O; Chinezu L; Comunoglu N; Cossu G; Cusimano M; Delgrange E; Earls P; Ezzat S; Gazioglu N; Grossman A; Guaraldi F; Hickman RA; Ikeda H; Jaffrain-Rea ML; Karavitaki N; Kraljević I; La Rosa S; Manojlović-Gačić E; Maartens N; McCutcheon IE; Messerer M; Mete O; Nishioka H; Oz B; Pakbaz S; Pekmezci M; Perry A; Reiniger L; Roncaroli F; Saeger W; Söylemezoğlu F; Tachibana O; Trouillas J; Turchini J; Uccella S; Villa C; Yamada S; Yarman S
    Pituitary; 2020 Jun; 23(3):322-325. PubMed ID: 31834538
    [No Abstract]   [Full Text] [Related]  

  • 9. Sarcomatous Transformation of a Medically Treated Lactotroph Pituitary Neuroendocrine Tumor?
    Terry M; Reis G; Horvai A; Pekmezci M; Perry A
    Endocr Pathol; 2023 Mar; 34(1):161-163. PubMed ID: 36826690
    [No Abstract]   [Full Text] [Related]  

  • 10. Pituitary neuroendocrine tumors: from old treatments to innovations, from efficacy to tolerance, from benignity to carcinomas, where do we stand now?
    Castinetti F; Raverot G
    Best Pract Res Clin Endocrinol Metab; 2022 Dec; 36(6):101717. PubMed ID: 36460564
    [No Abstract]   [Full Text] [Related]  

  • 11. Proposal of a clinically relevant working classification of pituitary neuroendocrine tumors based on pituitary transcription factors.
    Silva-Ortega S; García-Martinez A; Niveiro de Jaime M; Torregrosa ME; Abarca J; Monjas I; Picó Alfonso A; Aranda López I
    Hum Pathol; 2021 Apr; 110():20-30. PubMed ID: 33321163
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Case of an Immature PIT1-Lineage Pituitary Neuroendocrine Tumor of the Nasopharynx.
    Peters J; Gryn O; Gerka-Stuyt J
    Cureus; 2023 Sep; 15(9):e44985. PubMed ID: 37701167
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of AIP variants in pituitary adenomas and concomitant thyroid carcinomas in the Netherlands: a nationwide pathology registry (PALGA) study.
    Coopmans EC; Muhammad A; Daly AF; de Herder WW; van Kemenade FJ; Beckers A; de Haan M; van der Lely AJ; Korpershoek E; Neggers SJCMM
    Endocrine; 2020 Jun; 68(3):640-649. PubMed ID: 32333269
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Variable pathological and clinical features of a large Brazilian family harboring a mutation in the aryl hydrocarbon receptor-interacting protein gene.
    Naves LA; Daly AF; Vanbellinghen JF; Casulari LA; Spilioti C; Magalhães AV; Azevedo MF; Giacomini LA; Nascimento PP; Nunes RO; Rosa JW; Jaffrain-Rea ML; Bours V; Beckers A
    Eur J Endocrinol; 2007 Oct; 157(4):383-91. PubMed ID: 17893251
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Study of major genetic factors involved in pituitary tumorigenesis and their impact on clinical and biological characteristics of sporadic somatotropinomas and non-functioning pituitary adenomas.
    Foltran RK; Amorim PVGH; Duarte FH; Grande IPP; Freire ACTB; Frassetto FP; Dettoni JB; Alves VA; Castro I; Trarbach EB; Bronstein MD; Jallad RS
    Braz J Med Biol Res; 2018 Jun; 51(9):e7427. PubMed ID: 29947650
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mixed Sparsely Granulated Lactotroph and Densely Granulated Somatotroph Pituitary Neuroendocrine Tumor Expands the Spectrum of Neuroendocrine Neoplasms in Ovarian Teratomas: the Role of Pituitary Neuroendocrine Cell Lineage Biomarkers.
    Hodgson A; Pakbaz S; Shenouda C; Francis JA; Mete O
    Endocr Pathol; 2020 Sep; 31(3):315-319. PubMed ID: 32632841
    [No Abstract]   [Full Text] [Related]  

  • 17. Very low frequency of germline GPR101 genetic variation and no biallelic defects with AIP in a large cohort of patients with sporadic pituitary adenomas.
    Lecoq AL; Bouligand J; Hage M; Cazabat L; Salenave S; Linglart A; Young J; Guiochon-Mantel A; Chanson P; Kamenický P
    Eur J Endocrinol; 2016 Apr; 174(4):523-30. PubMed ID: 26792934
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Isolated familial somatotropinoma: 11q13-loh and gene/protein expression analysis suggests a possible involvement of aip also in non-pituitary tumorigenesis.
    Toledo RA; Mendonca BB; Fragoso MC; Soares IC; Almeida MQ; Moraes MB; Lourenço DM; Alves VA; Bronstein MD; Toledo SP
    Clinics (Sao Paulo); 2010 Apr; 65(4):407-15. PubMed ID: 20454499
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional characterization of DLK1/MEG3 locus on chromosome 14q32.2 reveals the differentiation of pituitary neuroendocrine tumors.
    Chen Y; Gao H; Liu Q; Xie W; Li B; Cheng S; Guo J; Fang Q; Zhu H; Wang Z; Wang J; Li C; Zhang Y
    Aging (Albany NY); 2020 Dec; 13(1):1422-1439. PubMed ID: 33472171
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular diagnosis of pituitary adenoma predisposition caused by aryl hydrocarbon receptor-interacting protein gene mutations.
    Georgitsi M; Raitila A; Karhu A; Tuppurainen K; Mäkinen MJ; Vierimaa O; Paschke R; Saeger W; van der Luijt RB; Sane T; Robledo M; De Menis E; Weil RJ; Wasik A; Zielinski G; Lucewicz O; Lubinski J; Launonen V; Vahteristo P; Aaltonen LA
    Proc Natl Acad Sci U S A; 2007 Mar; 104(10):4101-5. PubMed ID: 17360484
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.